Skip to content

The research of Tuna Huichun Gong on pulmonary function, exercise tolerance and quality of life in patients with chronic obstructive pulmonary disease based on the concept of early pulmona

The research of Tuna Huichun Gong on pulmonary function, exercise tolerance and quality of life in patients with chronic obstructive pulmonary disease based on the concept of early pulmona

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002849
Enrollment
Unknown
Registered
2019-12-19
Start date
2020-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

Group 2:basic medicine
Group 1:Tuna Huichun Gong exercise combined with basic medicine.

Sponsors

Affiliated Hospital of Chengdu Univercity of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of COPD, and the grade of COPD is ?-IV (post bronchodilator forced expiratory volume in 1 s (FEV1) / forced expiratory volume (FVC) < 70%, FEV1 < 80% predicted); (2) In the acute exacerbation period and the symptoms are basically relieved after treatment, or with only mild cough and a small amount of expectoration; (3) Ages are between 45 to 75 years; (4) have no damage on heart, liver, kidney and other vital organs; (5) Provision of written imformed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with other chronic respiratory diseases; (2) Patients with severe comorbidities, such as tumors, symptomatic cardiovascular diseases, myocardial infarction, neuromuscular diseases, etc. (3) Pregnant or lactating women; (4) Patients with AIDS, mental illness, and cognitive dysfunction; (5) Patients who are currently practicing traditional health Qigong exercises such as Gui-xing Gong, Baduanjin and TaiChi or are participating in other clinical drugs studies of COPD.

Design outcomes

Primary

MeasureTime frame
6 Minute Walk test;the St George's respiratory questionnaire;

Secondary

MeasureTime frame
Hospital anxiety and depression scale;CAT(COPD Assessment Test);mMRC;Pulmonary function test;

Countries

China

Contacts

Public ContactPengcheng Zhou
277694022@qq.com+86 17780015998

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026